Welcome to our dedicated page for Harley Davidson SEC filings (Ticker: HOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Harley-Davidson鈥檚 roaring V-Twin engines and its devoted rider community make every SEC filing more than routine compliance; they map the financial pulse behind an American icon. Whether you鈥檙e tracking how Adventure Touring or electric LiveWire sales flow through revenue lines or watching credit performance inside Harley-Davidson Financial Services, the details live here.
Use Stock Titan鈥檚 AI-powered summaries to turn the 200-page Harley-Davidson annual report 10-K simplified into a five-minute read, or to spot trends in a Harley-Davidson quarterly earnings report 10-Q filing before the market reacts. AG真人官方-time alerts flag each Harley-Davidson 8-K material events explained, while our dashboards surface Harley-Davidson insider trading Form 4 transactions the moment executives buy or sell shares. Still wondering 鈥淲hat does Harley-Davidson report in their SEC filings?鈥� or 鈥淗ow to read Harley-Davidson鈥檚 proxy statement executive compensation?鈥濃攐ur natural-language guides walk you through every section.
Here鈥檚 what you can do:
- Compare segment shipments quarter over quarter without wading through footnotes.
- Monitor Harley-Davidson Form 4 insider transactions real-time to gauge management sentiment.
- Review covenant metrics that keep HDFS credit losses in check.
- Set alerts for any Harley-Davidson earnings report filing analysis that revises outlook.
From the first factory whistle in 1903 to today鈥檚 connected bikes, the story unfolds in these filings. Stock Titan keeps you ahead with comprehensive coverage, plain-English explanations, and data that helps you ride confidently into your next investment decision.
United Therapeutics Corp. (UTHR) has received a Form 144 filing indicating a planned sale of 11,000 common shares through Morgan Stanley Smith Barney on or after 07/10/2025. The proposed transaction is valued at $3.30 million, based on the filing鈥檚 quoted market value. The company has 45.11 million shares outstanding, so the contemplated sale represents roughly 0.024 % of total shares.
The filer, identified as Paul Mahon, has been an active seller. Over the past three months, the same account reported seven Rule 144 sales totaling 66,000 shares for gross proceeds of about $19.38 million. Individual sale blocks were generally 11,000 shares, executed between 04/17/2025 and 06/26/2025 at prices that generated proceeds of $3.08鈥�$3.31 million per block.
While Rule 144 notices do not guarantee a sale will occur, they provide advance public disclosure of an insider or affiliate鈥檚 intent to transact. The filing also certifies that the seller is not in possession of undisclosed material adverse information and, if applicable, is operating under a Rule 10b5-1 plan.
Key take-aways for investors:
- Continuation of a steady liquidation pattern鈥攁n additional 11,000 shares planned after 66,000 shares already sold in the prior quarter.
- The cumulative 77,000 shares (0.17 % of shares outstanding) may point to portfolio diversification rather than a large strategic exit.
- No financial performance data or corporate developments are disclosed in the Form 144; the filing is limited to proposed share sales.